EpiMonitor

by Empatica Srl  · Based in Italy → — Welcome to the future of epilepsy monitoring.
Neurology Sleep Medicine

Paid subscription with device purchase
Regulatory Status Disclosed

Overview

EpiMonitor by Empatica is an FDA-cleared wearable medical device system designed for comprehensive epilepsy monitoring and seizure detection. It consists of the EmbracePlus smartwatch and a companion mobile application for iOS and Android. The system provides automated seizure alerts, sending calls and SMS messages with the user’s location to designated caregivers when a possible generalized tonic-clonic seizure is detected.

Beyond real-time alerts, EpiMonitor offers a user-friendly digital diary to track seizure events, triggers, and symptoms, which can be easily shared with healthcare providers. It also includes advanced features for tracking sleep quality and daily activity metrics, helping users and their doctors identify patterns and better manage their condition.

The device is prescription-only in the US and is cleared for use in adults and children aged 6 and up. It is important to note that EpiMonitor is a medical device for epilepsy monitoring and *not* a physician directory tool.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated seizure alerts (call and SMS with location) to caregivers
  • Self-triggered alerts for manual caregiver notification
  • Comprehensive digital seizure diary to log events, triggers, and symptoms
  • Accurate sleep tracking with advanced metrics
  • Daily activity tracking
  • Adjustable sensing precision for seizure detection
  • Up to 7 days of battery life for the EmbracePlus smartwatch
  • Ability to export seizure, sleep, and activity reports for physicians
  • False alarm cancellation feature

Use Cases

  • Continuous epilepsy monitoring for individuals aged 6 and up
  • Real-time seizure detection and caregiver notification
  • Personalized epilepsy management through data tracking and insights
  • Facilitating communication between patients and healthcare providers
  • Supporting independence and peace of mind for individuals with epilepsy and their families
  • Data collection for clinical research studies (as part of Empatica Health Monitoring Platform)

What Physicians Need to Know

Seizure Detection
EpiMonitor is an FDA-cleared and CE-certified medical-grade solution for detecting generalized tonic-clonic seizures (GTCS) lasting over 20 seconds. It boasts a 98% accuracy rate and a low false alarm rate, utilizing a combination of electrodermal activity (EDA) and movement data. The system offers adjustable sensing precision to minimize false alerts and allows for manual alert triggering.
Triage Prioritization Speed
Upon detection of a possible seizure, EpiMonitor initiates a 15-second countdown, allowing the user to cancel false alarms. If not canceled, alerts are instantly sent to designated caregivers via automated phone calls and SMS messages. Caregivers receive the user's location, depending on the subscription plan, for prompt assistance.
Mobile Notification System
The system relies on a companion EpiMonitor app, compatible with both iOS and Android smartphones, to send alerts. Alerts are delivered to designated caregivers via phone calls and SMS, regardless of their proximity to the user, as long as they have a working phone. The EmbracePlus watch communicates with the smartphone via Bluetooth, and the smartphone requires an active internet connection to trigger alerts through the Empatica Cloud.
Physician Tip

EpiMonitor is an FDA-cleared and CE-certified prescription-only medical device in the US, indicated as an adjunct for generalized tonic-clonic seizure monitoring in adults and children aged 6 and up. It should supplement, not replace, existing seizure management practices and should not be used for medical or diagnostic decisions. The system provides a comprehensive seizure, sleep, and activity diary that can be exported as a PDF for review and discussion with healthcare providers, aiding in identifying trends and optimizing epilepsy management. Empatica is also conducting a study to develop a seizure forecasting algorithm, in which EpiMonitor users can participate.

The EpiMonitor system comprises the EmbracePlus wearable watch and a dedicated EpiMonitor mobile application, compatible with iOS and Android smartphones. For functionality, the EmbracePlus watch requires a Bluetooth connection to the user's smartphone (within 5 meters/15 feet), and the smartphone needs an active internet connection (Wi-Fi or cellular) to transmit data to the Empatica Cloud and trigger caregiver alerts. While it provides exportable PDF reports for sharing with clinicians, there is no explicit mention of direct integration with Electronic Medical Records (EMR) or other third-party neurology/neuroimaging platforms.

Details

Category Neurology AI, Wearables & Remote Monitoring (RPM)
Pricing Paid subscription with device purchase
  • One-time device fee: $399 (EmbracePlus); Monthly subscriptions starting at $17.40; Tiers: Basic, Standard, Plus; Annual subscription discounts available
DeploymentWearable device (EmbracePlus smartwatch) paired with a smartphone app (iOS/Android) and cloud-based data infrastructure.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

EpiMonitor (K250515) received FDA clearance on June 19, 2025, as a prescription-only medical device system intended as an adjunct to seizure monitoring in adults and children aged 6 and up, detecting patterns associated with generalized tonic-clonic seizures.

Integrations
EHR Not specified
Specialties Neurology, Sleep Medicine

What the Web Says

EpiMonitor by Empatica is an FDA-cleared wearable device and app system designed for epilepsy monitoring, detecting possible convulsive seizures, and tracking related health data. It aims to provide peace of mind for users and caregivers by sending automated alerts. While it offers features like a seizure diary, sleep and activity tracking, and a long battery life, user reviews indicate a mixed experience, with significant concerns regarding false alarms, connectivity issues, and the overall cost and subscription model.

Overall: Mixed

Strengths

  • FDA-cleared for seizure detection in adults and children aged six and above.
  • Long battery life (up to 7 days) and quick charging.
  • Automated and manual real-time seizure alerts for caregivers via phone calls and SMS.
  • Comprehensive epilepsy and seizure diary, including sleep and activity tracking.
  • Improved seizure alert capabilities and fewer false alarms compared to its predecessor (Embrace2).
  • Adjustable alert sensitivity controls to reduce false alarms.

Limitations

  • Frequent false alarms, often triggered by everyday movements.
  • Connectivity issues, with the device often disconnecting from Bluetooth.
  • Requires the patient's phone to be in close proximity, making it impractical for children without phones or for independent movement.
  • High cost of the device and expensive subscription fees, with essential features locked behind higher tiers.
  • Poor app functionality, including difficulty navigating account settings, inaccurate sleep data, and a non-user-friendly interface.
  • Customer support and availability are reported to be excruciating.

Based on reviews from: Apple App Store, Reddit, Epilepsy Action, Google Play Store

Last updated: 2026-07-21

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate EpiMonitor

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Empatica
Empatica launches FDA-cleared EpiMonitor for epilepsy with AI seizure forecasting study
Empatica launched EpiMonitor, an FDA-cleared wearable for epilepsy monitoring, featuring enhanced seizure alerts, extended battery life, and advanced health insights. The device is cleared for adults and children aged 6 and up and utilizes a smart algorithm with 98% accuracy for automatic seizure detection.
2024-02
Business Wire
Empatica Achieves CE MDR Certification for EpiMonitor, Bringing Round-the-Clock Epilepsy Monitoring to Europe
Following its successful US launch and FDA clearance, Empatica's EpiMonitor has achieved CE MDR certification, making it available in Europe. This medical-grade wearable and app combination offers seizure detection, alerting, and continuous health monitoring.
2025-05
Empatica
EpiMonitor expands to Australia, New Zealand, and Canada
EpiMonitor is now available in Australia, New Zealand, and Canada, thanks to new regulatory milestones, expanding advanced epilepsy monitoring to more people globally. It is listed in the Australian Register of Therapeutic Goods (ARTG ref: 524726) and licensed by Health Canada (Medical Device License #115081).
2026-03
Empatica
Erin's Embrace Program: Expanding Access to Seizure Monitoring
The Erin's Embrace Program helps families access EpiMonitor seizure monitoring technology, reflecting Empatica's goal to make such devices accessible despite current limitations in government or insurance coverage. Eligible patients with a valid prescription can receive an Empatica device at no cost.
2026-05
Empatica
Introducing a new look for EpiMonitor | More colors and sizes for a journey that's uniquely yours
Empatica introduced a new look for EpiMonitor, offering more color and size options for the EmbracePlus wearable's stretchable band. This aims to provide users with personalized, comfortable, and unobtrusive medical-grade wearables for daily wear.
2025-06
Medical Device and Diagnostic Industry
Empatica Launch EpiMonitor Epilepsy watch
Empatica launched its next-generation FDA-cleared EpiMonitor watch, which is cleared for use in adults and children aged six and up for seizure detection. It is described as the only wearable solution with regulatory clearance for seizure detection available for purchase in the United States.
2024-03
Empatica
EpiMonitor, the world's only medical-grade epilepsy watch, is now available in Europe
Following its successful US launch and FDA clearance, Empatica's EpiMonitor is now a CE-certified device according to EU Medical Device Regulation 2017/745 and available in Europe. It provides automatic generalized tonic-clonic seizure detection with 98% accuracy and alerts caregivers.
2025-04
Empatica
New EpiMonitor Diary: Real insights for better epilepsy management
Empatica introduced enhanced data visualization for its FDA-cleared EpiMonitor, featuring a new intuitive 'My Diary' design for sleep, activity, and seizures. This update provides deeper wellness insights and a summary screen with daily data for better epilepsy management.
2024-11

Videos

Product demos, reviews, and walkthroughs for EpiMonitor.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

EpiMonitor consists of a wearable device and a smartphone app that passively monitors physiological data and alerts caregivers to possible generalized tonic-clonic seizures. Physicians can access recorded seizure, sleep, and activity reports, which can be exported and shared for retrospective review via cloud-based software.
EpiMonitor is an FDA-cleared, prescription-only medical device system for adults and children aged 6 and up, indicating it has undergone rigorous review for safety and efficacy. As an FDA-cleared medical device handling patient data, it is expected to adhere to relevant privacy regulations, including cybersecurity assessments during its clearance process.
EpiMonitor boasts a 98% accuracy in detecting generalized tonic-clonic seizures with a low false alarm rate, but it does not predict seizure onset and is not intended for strenuous activity or to guide medical therapy decisions. Its effectiveness is specifically established for generalized tonic-clonic seizures, not other seizure types, and it should not be used as a stand-alone monitoring device.
EpiMonitor transmits sensor data and computed physiological parameters to the Empatica Cloud for secure storage and review by healthcare professionals. As an FDA-cleared medical device, it undergoes extensive testing related to cybersecurity, implying robust measures are in place to protect patient information.
EpiMonitor is highlighted as the only wearable solution with FDA clearance for seizure detection available for purchase in the United States, offering high accuracy (98%) and a low false alarm rate. It provides automated and self-triggered alerts to caregivers, along with comprehensive health insights like seizure, sleep, and activity reports.
EpiMonitor is a prescription-only medical device in the US, indicating it's acquired through a physician's order. While specific pricing models are not detailed in the provided information, it generally involves a purchase of the EmbracePlus wearable and access to the companion app and cloud services, likely through a subscription or one-time fee.
EpiMonitor is FDA-cleared, a process that involves extensive and independent review of clinical data demonstrating safety and effectiveness. Its seizure detection algorithm is trained on thousands of hours of clinical data, with a 98% detection accuracy against the gold standard of hospital-based EEG measurement.

Related Tools

Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
CoLumbo C-Spine
Smart Soft Healthcare AD
Clinical Decision Support & Reference
CoLumbo C-Spine is an AI-powered software that processes and analyzes cervical spine MRI exams, assisting clinicians in diagnosis and assessment.
MeRT System
Wave Neuroscience
Mental & Behavioral Health AI
MeRT (Magnetic e-Resonance Therapy) is an advanced, personalized form of TMS that uses your own brainwave data to guide treatment. It's a non-invasive, drug-free option designed to help the brain communicate more efficiently so symptoms of conditions like depression, anxiety, PTSD, TBI, autism, and more can improve.
Brainomix 360 Hyperdensity
Brainomix Limited
Neurology AI
Brainomix 360 Hyperdensity is an AI-powered neuroimaging software tool that detects and quantifies brain hyperdensities on CT scans, forming a crucial part of the Brainomix 360 Stroke platform for rapid and accurate stroke assessment.
SOMNUM
HoneyNaps
Clinical Decision Support & Reference
SOMNUM is an AI-enabled medical software tool by Honeynaps Co., Ltd. that provides comprehensive sleep analysis to aid in the diagnosis and management of sleep disorders.
DETECT-ME/CFS project
DETECT-ME/CFS project (ME/CFS Research Foundation)
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

See all Neurology AI tools →

More from Empatica Srl

Embrace
Empatica Srl
Neurology AI
Embrace by Empatica is an AI-powered wearable biosensor device for seizure monitoring in individuals with epilepsy, detecting generalized tonic-clonic seizures and alerting caregivers. It also tracks sleep, rest, and physical activity.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-21 | First Added: 2026-04-21
AI Tool Finder
AI-powered search. Results may not be comprehensive.